BIOCOF EXPECTORANT

Indications

• Hepatic encephalopathy
• Urea cycle disorders
• Metabolic alkalosis
• Acid-base balance disorders

Dosage

Children: Refer to pediatric dosing guidelines provided in clinical references, as doses depend on the specific condition and the child's age and weight.

Adults: Refer to specific clinical guidelines for adult dosing recommendations, as they can vary based on the condition being treated and individual patient factors.

Mechanism of action

Ammonium acts primarily as a nitrogen donor in the urea cycle, facilitating the conversion of ammonia to urea for excretion. This process helps to detoxify ammonia, which is a byproduct of protein metabolism. In the liver, ammonia is converted to ammonium, which then enters the urea cycle for further processing. Additionally, ammonium can influence acid-base homeostasis by participating in buffering reactions in the kidneys.

Pharmacodynamics

The pharmacodynamics of ammonium are closely related to its role in nitrogen metabolism and acid-base balance. By increasing the excretion of nitrogenous waste through urea formation, ammonium helps to lower blood ammonia levels, which can be toxic at elevated concentrations. Furthermore, ammonium ions can affect intracellular pH and influence neurotransmitter release, particularly in the central nervous system, which is relevant in conditions like hepatic encephalopathy.

Pharmacokinetics

Ammonium is rapidly absorbed and distributed in the body. It can cross cellular membranes, influencing intracellular and extracellular fluid composition. Ammonium is primarily eliminated through renal excretion, where it can be excreted as free ammonium or as part of urea. The half-life of ammonium in the body is not well-defined, as it is continuously produced and eliminated depending on metabolic activity and dietary protein intake.

Contra-indications

• Severe renal impairment
• Hypersensitivity to ammonium compounds

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Dizziness
• Headache
• Confusion
• Tremors
• Respiratory depression

Interactions

• May enhance the effects of neuromuscular blocking agents
• May interact with other central nervous system depressants

Precautions

• Use with caution in patients with liver disease
• Monitor electrolytes in patients with renal impairment
• Caution in patients with a history of seizures

Pregnancy

Safety in pregnancy has not been established. Use only if clearly needed and the benefits outweigh the risks.

Breast-feeding

Use with caution. Monitor the infant for any adverse effects.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.

Formulations

• Ammonium chloride solution
• Ammonium sulfate
• Ammonium hydroxide

Indications

• Heart failure
• Edema
• Hypertension
• Congestive heart failure

Dosage

Children: Refer to the BNF for Children for specific dosage information regarding squill in paediatric patients.

Adults: Refer to the BNF for specific dosage information regarding squill in adults.

Mechanism of action

Squill contains cardiac glycosides, which inhibit the Na+/K+ ATPase enzyme. This inhibition leads to an increase in intracellular sodium levels, which causes an increase in intracellular calcium levels via the sodium-calcium exchanger. This results in enhanced myocardial contractility (positive inotropic effect) and a reduction in heart rate (negative chronotropic effect). Additionally, squill promotes diuresis by increasing renal blood flow and glomerular filtration rate.

Pharmacodynamics

The positive inotropic effect of squill enhances cardiac output and is useful in the management of certain heart conditions. The diuretic effect aids in fluid management, making it beneficial for patients with heart failure or edema. However, the therapeutic window is narrow, and toxicity can occur with overdose, leading to arrhythmias and gastrointestinal disturbances.

Pharmacokinetics

The pharmacokinetics of squill have not been extensively studied. However, it is generally understood that the active glycosides are absorbed in the gastrointestinal tract, with peak plasma concentrations occurring within a few hours after ingestion. The elimination half-life is variable and depends on the specific glycoside. The metabolites are primarily excreted via the kidneys.

Pregnancy

The safety of squill during pregnancy has not been established. Use only if clearly needed and prescribed by a healthcare provider.

Breast-feeding

It is not known whether squill is excreted in human milk. Caution should be exercised when administering to breastfeeding women.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Herbal remedy for anxiety
• Support for digestive health
• Anti-inflammatory support
• Antimicrobial effects
• Pain relief
• Support for immune function

Dosage

Children: Refer to specific tincture product instructions for dosage, as this varies significantly based on the plant and concentration.

Adults: Refer to specific tincture product instructions for dosage, as this varies significantly based on the plant and concentration.

Mechanism of action

The mechanism of action of tinctures depends on the specific herbs or plants used in their preparation. Generally, the active compounds extracted from the plant material interact with various biological pathways, including receptor modulation, enzyme inhibition, and antioxidant activity. For example, flavonoids and alkaloids found in many tinctures may exhibit anti-inflammatory, analgesic, or antimicrobial effects through their interaction with cellular signaling pathways.

Pharmacodynamics

The pharmacodynamics of tinctures is influenced by the specific constituents of the herbal material. These constituents may exert effects such as enhancing or inhibiting neurotransmitter activity, modulating inflammatory responses, or influencing metabolic pathways. The effects can vary widely among different tinctures based on the plant used, the extraction method, and the concentration of the active ingredients.

Pharmacokinetics

The pharmacokinetics of tinctures involves absorption, distribution, metabolism, and excretion of the active compounds. After administration, the alcohol or vinegar solvent aids in the rapid absorption of these compounds through the mucosal membranes or gastrointestinal tract. Once absorbed, the compounds are distributed throughout the body and may undergo metabolic transformations primarily in the liver. The elimination half-life varies based on the specific herb and its active constituents, with some compounds being excreted unchanged while others are metabolized into active or inactive metabolites.

Contra-indications

• Hypersensitivity to any component of the tincture
• Severe liver disease
• Pregnancy (specific tinctures may vary)

Adverse effects

• Skin irritation
• Allergic reactions
• Gastrointestinal upset
• Drowsiness or sedation (depending on the active ingredient)

Interactions

• May interact with alcohol, increasing sedative effects
• Potential interactions with other CNS depressants
• May affect the metabolism of certain drugs via hepatic pathways

Precautions

• Use cautiously in patients with a history of substance abuse
• Monitor liver function in patients with liver disease
• Caution in operating machinery or driving due to potential drowsiness

Pregnancy

Generally not recommended during pregnancy due to potential risks associated with alcohol and other active ingredients.

Breast-feeding

Caution is advised, as components may pass into breast milk and affect the infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep tightly closed and out of reach of children.

Formulations

• Tinctures of various herbs and compounds, including but not limited to: echinacea, valerian, and calendula